Scholars Central

Conference abstract

Nasal vaccine as a tool for conferring rapid-sustained-broad protection against pathogens without inducing systemic inflammation

Authors: De-chu Christopher Tang

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

W e report that intranasal administration of a nonreplicating Ad5 ( ∆ E1E3 Ad5)-vectored influenza vaccine could induce seroconversion in human volunteers without appreciable adverse effects, even in subjects with pre-existing Ad5 immunity. Mice and ferrets were well protected against challenge by a lethal dose of an H5N1 avian influenza virus following intranasal instillation of an Ad5-vectored influenza vaccine in a single-dose regimen. Moreover, the ∆ E1E3 Ad5 particle itself without transgene could confer rapid-sustained-broad protection against influenza by inducing an anti-influenza state in a drug-like manner. An Ad5-HA vector thus consolidates drug and vaccine into a single package, which allows the Ad5 backbone to induce protective innate immunity capable of conferring nearly-immediate and prolonged (e.g., 5 hours to 47 days) protection as the first wave against influenza; followed by HA-mediated adaptive immunity as the second wavebefore the innate immunity-associated anti-influenza state declines away. In addition to ∆ E1E3 Ad5?s capacity to rapidly induce an anti-influenza state, an Ad5 vector encoding a bioengineered Bacillus anthracis protective antigen (PA) could also confer rapid (e.g., 1-2 days) prophylactic or post-exposure anthrax therapy with synergy to antibiotic treatment in a murine model. Both rabbits and macaques were well protected by an Ad5-PA-vectored nasal anthrax vaccine in a single-dose regimen against inhalation anthrax following challenge with a lethal dose of Bacillus anthracis Ames spores. Overall, the nonreplicating nasal vaccine capable of inducing protective innate-adaptive immunity duo represents an entirely new line of holistic thinking about vaccinology at its core

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Vaccines & Vaccination
  • SubjectVaccines & Immunisation
  • BylineArticles whose byline prints “De-chu Christopher Tang”